Diseases, Conditions, Syndromes

Immune responses to tuberculosis mapped across three species

Tuberculosis (TB) is one of the world's most vexing public health problems. About 1.5 million people died from this bacterial lung infection in 2018, and the World Health Organization (WHO) estimates that one-quarter of the ...

Diseases, Conditions, Syndromes

Researchers move closer to new vaccine for killer TB

Scientists said Tuesday they are closing in on a new game-changing vaccine for tuberculosis, the world's deadliest infectious disease that claimed some 1.5 million lives last year.

Diseases, Conditions, Syndromes

Tuberculosis mutation discovery paves way for better treatments

A Rutgers New Jersey Medical School study has found a genetically tractable cause of drug tolerant tuberculosis, paving the way for researchers to develop new drugs to combat the global TB epidemic and cure the disease.

Diseases, Conditions, Syndromes

Study maps genetics of early progression in tuberculosis

While the vast majority of the 1.8 billion people infected with the TB bacterium never experience active disease, an estimated 5 to 15 percent do develop full-blown infections—roughly half of them within 18 months of exposure.

Diseases, Conditions, Syndromes

New vaccine targets killer disease tuberculosis

There is only one existing vaccine for TB and it is not effective in adults. Researchers at the Centenary Institute and University of Sydney will next test their new vaccine in clinical trials with humans.

page 7 from 40